← FDA Drug Approvals (Drugs@FDA)

BETAINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ETON · Approved 2022-01-28

Drug application

FDA Application #

ANDA210508

Application type

Abbreviated New Drug Application (Generic)

Brand name

BETAINE

Generic name

BETAINE ANHYDROUS

Active ingredients

BETAINE

Dosage form

FOR SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

ETON

Manufacturer

Eton Pharmaceuticals, Inc.

First approval

2022-01-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown